ジェネリック医薬品メーカーベンチマークレポート...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 11
2 Introduction 13
2.1 Report Scope 13
2.2 Upcoming Related Reports 15
2.3 Recently Published Reports 15
2.4 GlobalData’s Benchmarking Methodology 16
3 GlobalData Benchmark Rankings 17
3.1 Sun Pharmaceuticals Emerges as Generics Leader 17
4 Financial Management 19
4.1 Competitive Framework 19
4.2 Overview 19
4.3 Financial Management: Heat Map 22
4.4 Financial Metrics 24
4.4.1 Revenue Leaders 24
4.4.2 Revenue Laggards 26
4.4.3 Revenue Growth Leaders 28
4.4.4 Revenue Growth Laggards 30
4.4.5 Operating Income Leaders 32
4.4.6 Operating Income Laggards 33
4.4.7 Operating Income YTY Growth Leaders 35
4.4.8 Operating Income YTY Growth Laggards 36
4.4.9 Operating Margin Leaders 39
4.4.10 Operating Margin Laggards 40
5 Expense Management 43
5.1 Competitive Framework 43
5.2 Overview 43
5.3 Expense Management: Heat Map 46
5.4 Expense Metrics 48
5.4.1 SG&A Spending Leaders 48
5.4.2 SG&A Spending Laggards 49
5.4.3 SG&A YTY Change Leaders 51
5.4.4 SG&A YTY Change Laggards 52
5.4.5 Operating Expense Leaders 54
5.4.6 Operating Expense Laggards 55
6 Capital Management 58
6.1 Competitive Framework 58
6.2 Overview 58
6.3 Competitive Framework: Heat Map 60
6.4 Capital Management Metrics 61
6.4.1 Debt-to-Assets Leaders 61
6.4.2 Debt-to-Assets Laggards 63
6.4.3 Cash Ratio Leaders 65
6.4.4 Cash Ratio Laggards 67
6.4.5 ROI Leaders 69
6.4.6 ROI Laggards 70
7 Key Players 72
7.1 Strategic Analysis of Leading Generics Players 72
7.1.1 Sun Pharmaceuticals: The Benchmark Leader 72
7.1.2 Sandoz 76
7.1.3 Pharmstandard 79
7.1.4 Teva Pharmaceuticals 81
7.1.5 Actavis 86
7.1.6 Mylan 90
7.1.7 Ranbaxy 93
7.1.8 Dr. Reddy’s 94
7.1.9 Covidien 95
7.1.10 Hospira 96
8 Outlook 97
8.1 Leverage Improvement will Significantly Alter 2013 Benchmark Rankings 97
8.2 Generic Manufacturers in Emerging Markets will continue to Challenge for Top Spots 97
9 Appendix 99
9.1 Bibliography 99
9.2 Abbreviations 99
9.3 Research Methodology 101
9.3.1 Coverage 101
9.3.2 Secondary Research 102
9.3.3 Expert Panel Validation 102
9.4 About the Authors 102
9.4.1 Analyst 102
9.4.2 Director of Healthcare Industry Dynamics 103
9.4.3 Global Head of Healthcare Research and Consulting 103
9.5 About the Industry Dynamics Team 104
9.6 About GlobalData 104
9.7 Contact Us 104
9.8 Disclosure Information 105
9.9 Disclaimer 105